Nifty

:

17327.35

Sensex

:

58098.92

-302.45 (-1.72%)
-1020.80 (-1.73%)

Login

Nifty
Sensex

:
:

17327.35
58098.92

-302.45 (-1.72%)
-1020.80 (-1.73%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

59/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

1404.25

23-Sep-2022

Day's Open
Day's High
Day's Low
Previous Close

1418.05
1424.80
1397.15
1418.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

61933
872.48
1918.75
1372.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

23,788.00
14.03
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

21,303.49
6.41%
8.55

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
2.68
0.55

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
8.54
3.00

PAT CAGR (%)

10 Years
5 Years
3 Years

-
1.66
59.86

P:E (Median)

8 Years
5 Years
3 Years

60.81
61.82
60.78

P:BV (Average)

8 Years
5 Years
3 Years

13.82
13.52
15.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

35.41
33.95
31.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 729.46 701.84 3.94% 791.92 737.95 7.31% 807.98 793.09 1.88% 991.53 879.39 12.75%
Expenses 581.53 570.10 2.00% 618.50 583.36 6.02% 611.32 611.15 0.03% 717.14 674.37 6.34%
EBITDA 147.93 131.74 12.29% 173.42 154.59 12.18% 196.66 181.94 8.09% 274.39 205.02 33.84%
EBIDTM 20.28% 18.77% 21.90% 20.95% 24.34% 22.94% 27.67% 23.31%
Other Income 27.79 31.73 -12.42% 18.94 29.61 -36.04% 10.50 13.87 -24.30% 15.05 8.92 68.72%
Interest 0.68 0.79 -13.92% 0.27 0.63 -57.14% 0.58 0.94 -38.30% 0.35 0.88 -60.23%
Depreciation 15.82 17.54 -9.81% 15.35 17.68 -13.18% 17.87 17.54 1.88% 17.60 21.96 -19.85%
PBT 159.22 145.14 9.70% 206.24 46.89 339.84% 170.79 187.86 -9.09% 271.49 126.97 113.82%
Tax 43.59 38.54 13.10% 262.11 44.82 484.81% 33.23 47.77 -30.44% 68.84 50.47 36.40%
PAT 115.63 106.60 8.47% -55.87 2.07 - 137.56 140.09 -1.81% 202.65 76.50 164.90%
PATM 15.85% 15.19% -7.05% 0.28% 17.03% 17.66% 20.44% 8.70%
EPS 6.83 6.29 8.59% -3.30 0.12 - 8.12 8.27 -1.81% 11.96 4.52 164.60%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 745.10 718.37 3.72% 809.63 744.43 8.76% 815.92 791.87 3.04% 1,009.87 879.32 14.85%
Expenses 596.18 585.65 1.80% 634.41 587.75 7.94% 618.11 611.21 1.13% 733.35 674.46 8.73%
EBITDA 148.92 132.72 12.21% 175.22 156.68 11.83% 197.81 180.66 9.49% 276.52 204.86 34.98%
EBIDTM 19.99% 18.48% 21.64% 21.05% 24.24% 22.81% 27.38% 23.30%
Other Income 27.61 31.73 -12.98% 18.76 29.60 -36.62% 10.32 14.02 -26.39% 14.97 9.04 65.60%
Interest 0.68 0.79 -13.92% 0.28 0.63 -55.56% 0.58 0.94 -38.30% 0.35 0.88 -60.23%
Depreciation 15.82 17.54 -9.81% 15.35 17.68 -13.18% 17.87 17.54 1.88% 17.60 21.96 -19.85%
PBT 160.03 146.12 9.52% 207.85 48.97 324.44% 171.76 186.73 -8.02% 273.54 126.93 115.50%
Tax 43.80 38.84 12.77% 262.51 45.32 479.24% 33.48 47.48 -29.49% 69.30 50.46 37.34%
PAT 116.23 107.28 8.34% -54.66 3.65 - 138.28 139.25 -0.70% 204.24 76.47 167.09%
PATM 15.60% 14.93% -6.75% 0.49% 16.95% 17.59% 20.22% 8.70%
EPS 7.04 7.15 -1.54% 71.96 0.85 8,365.88% 8.87 9.24 -4.00% 12.06 4.51 167.41%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Net Sales 3,320.89 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 2,591.16 2,671.83 Net Sales Growth 6.70% 10.17% -9.43% 3.07% 8.94% -1.08% 2.72% -15.53% 29.13% -3.02% Cost Of Goods Sold 1,302.35 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 1,166.02 1,094.24 Gross Profit 2,018.54 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 1,425.14 1,577.58 GP Margin 60.78% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% 55.00% 59.04% Total Expenditure 2,528.49 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 2,114.09 1,901.95 Power & Fuel Cost - 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 22.50 % Of Sales - 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.92% 0.84% Employee Cost - 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 362.05 295.52 % Of Sales - 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% 13.97% 11.06% Manufacturing Exp. - 120.14 110.59 107.88 115.19 110.55 108.26 117.67 365.85 127.72 113.57 % Of Sales - 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% 4.93% 4.25% General & Admin Exp. - 143.99 117.27 164.31 178.51 203.43 194.72 154.34 177.98 134.79 125.55 % Of Sales - 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% 5.20% 4.70% Selling & Distn. Exp. - 200.23 124.73 212.36 202.81 154.38 178.88 164.26 222.32 186.27 160.50 % Of Sales - 6.22% 4.27% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% 7.19% 6.01% Miscellaneous Exp. - 63.53 78.51 111.89 106.88 104.29 96.61 125.19 164.01 113.38 160.50 % Of Sales - 1.97% 2.69% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% 4.38% 3.37% EBITDA 792.40 755.83 597.78 658.45 606.48 508.44 419.94 476.75 568.79 477.07 769.88 EBITDA Margin 23.86% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% 18.41% 28.81% Other Income 72.28 76.22 110.19 77.56 101.48 53.52 72.01 122.25 257.53 246.31 243.07 Interest 1.88 1.99 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 0.33 Depreciation 66.64 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 19.88 17.84 PBT 807.74 761.87 625.83 646.99 658.82 523.78 465.35 573.63 800.50 703.17 994.78 Tax 407.77 396.87 166.54 212.45 238.35 189.60 174.30 201.41 276.98 227.44 269.30 Tax Rate 50.48% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% 31.19% 31.81% PAT 399.97 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 501.88 577.26 PAT before Minority Interest 399.97 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 501.88 577.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.04% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% 19.37% 21.61% PAT Growth 22.97% 31.35% 160.51% -74.13% 20.84% 4.52% -10.08% -20.59% -6.02% -13.06% EPS 23.61 22.23 16.92 6.50 25.11 20.78 19.88 22.11 27.84 29.63 34.08

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Net Sales 3,380.52 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 2,607.70 2,692.06 Net Sales Growth 7.87% 12.05% -9.27% 3.08% 8.94% -1.27% 2.49% -15.61% 28.96% -3.13% Cost Of Goods Sold 1,361.53 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 1,171.68 1,100.57 Gross Profit 2,018.99 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 1,436.02 1,591.49 GP Margin 59.72% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% 55.07% 59.12% Total Expenditure 2,582.05 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 2,124.49 1,915.22 Power & Fuel Cost - 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 22.50 % Of Sales - 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.91% 0.84% Employee Cost - 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 362.05 295.52 % Of Sales - 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% 13.88% 10.98% Manufacturing Exp. - 120.14 110.59 107.89 115.55 110.55 108.26 118.09 367.24 127.78 113.62 % Of Sales - 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% 4.90% 4.22% General & Admin Exp. - 144.08 117.31 164.51 178.60 204.45 195.08 154.85 178.21 135.34 126.10 % Of Sales - 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% 5.19% 4.68% Selling & Distn. Exp. - 200.23 124.73 212.36 202.81 154.38 178.91 164.47 222.31 186.23 160.74 % Of Sales - 6.11% 4.26% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% 7.14% 5.97% Miscellaneous Exp. - 57.45 75.74 112.58 107.20 105.12 98.67 127.99 168.72 117.55 160.74 % Of Sales - 1.75% 2.59% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% 4.51% 3.57% EBITDA 798.47 761.88 598.14 657.25 600.80 505.79 418.98 478.27 574.58 483.21 776.84 EBITDA Margin 23.62% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% 18.53% 28.86% Other Income 71.66 75.78 110.58 79.01 102.32 54.54 73.07 123.18 258.80 222.30 223.90 Interest 1.89 2.00 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 0.33 Depreciation 66.64 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 19.88 17.84 PBT 813.18 767.47 626.59 647.25 653.97 522.17 465.46 576.08 807.56 685.30 982.58 Tax 409.09 398.28 166.72 212.55 237.28 189.24 174.37 202.25 279.27 229.78 272.48 Tax Rate 50.31% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% 32.30% 32.66% PAT 404.09 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 481.67 561.88 PAT before Minority Interest 404.09 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 481.67 561.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.95% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% 18.47% 20.87% PAT Growth 23.71% 32.55% 208.23% -79.07% 26.99% 4.13% -10.46% -21.05% -1.09% -14.28% EPS 23.85 22.48 16.96 5.50 26.29 20.70 19.88 22.20 28.12 28.43 33.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Shareholder's Funds 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 2,017.19 2,010.02 Share Capital 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 1,932.49 1,925.31 Non-Current Liabilities 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 157.51 157.36 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 4.14 Long Term Provisions 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 241.04 234.79 Current Liabilities 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 883.07 835.75 Trade Payables 546.63 447.99 354.19 402.96 502.53 275.92 323.09 305.89 278.01 235.19 Other Current Liabilities 503.54 433.09 205.84 802.59 842.33 391.18 203.59 131.56 86.22 88.35 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 624.18 438.35 442.04 1,595.07 1,600.30 211.22 48.18 668.42 518.83 512.21 Total Liabilities 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 3,057.77 3,003.13 Net Block 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.06 100.07 89.40 Gross Block 606.40 600.65 1,452.35 559.05 405.89 299.09 228.36 319.19 299.08 272.04 Accumulated Depreciation 275.52 215.09 695.76 129.06 83.08 46.38 24.32 196.13 199.01 182.63 Non Current Assets 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 456.03 390.73 Capital Work in Progress 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 Non Current Investment 25.68 25.82 25.97 26.17 49.43 52.99 53.63 47.67 47.67 57.68 Long Term Loans & Adv. 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 232.87 189.69 Other Non Current Assets 5.44 7.03 7.17 7.84 4.75 6.47 0.06 11.12 13.55 10.18 Current Assets 3,670.71 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 2,601.73 2,612.40 Current Investments 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 44.91 Inventories 512.71 523.34 483.03 486.49 500.18 425.48 521.66 368.86 342.40 282.04 Sundry Debtors 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 115.90 Cash & Bank 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 2,027.14 2,038.78 Other Current Assets 108.05 218.22 48.43 111.96 1,585.33 332.19 121.90 197.99 125.80 130.77 Short Term Loans & Adv. 28.39 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 68.16 55.79 Net Current Assets 1,996.36 851.90 754.71 540.31 567.01 932.39 1,572.94 1,459.32 1,718.67 1,776.65 Total Assets 4,509.81 2,995.41 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48 3,057.76 3,003.13

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Shareholder's Funds 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 1,989.73 2,006.83 Share Capital 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 1,905.03 1,922.13 Non-Current Liabilities 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 158.59 158.45 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 4.14 Long Term Provisions 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 242.29 236.05 Current Liabilities 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 888.91 836.40 Trade Payables 570.55 466.13 357.06 405.81 505.86 278.93 327.74 308.04 285.63 237.37 Other Current Liabilities 503.70 450.11 222.85 802.71 842.35 390.47 202.82 130.09 84.13 86.82 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 624.18 438.35 442.04 1,595.54 1,600.77 211.69 253.08 668.42 519.15 512.21 Total Liabilities 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 3,037.23 3,001.68 Net Block 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.08 100.09 89.42 Gross Block 606.40 600.65 1,452.35 559.05 405.89 299.09 228.36 363.34 343.22 316.18 Accumulated Depreciation 275.52 215.09 695.76 129.06 83.08 46.38 24.32 240.26 243.13 226.76 Non Current Assets 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 413.30 355.01 Capital Work in Progress 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 Non Current Investment 1.21 1.35 1.49 1.69 1.84 5.40 6.04 0.06 0.06 10.06 Long Term Loans & Adv. 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 237.73 194.55 Other Non Current Assets 5.45 7.05 7.17 7.84 4.75 6.47 0.06 11.13 13.55 17.19 Current Assets 3,708.03 2,202.64 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 2,623.94 2,646.67 Current Investments 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 44.91 Inventories 534.70 546.70 483.03 486.49 500.18 425.80 525.87 375.58 346.97 285.15 Sundry Debtors 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 115.90 Cash & Bank 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 2,041.58 2,066.77 Other Current Assets 118.00 225.89 48.58 112.30 1,591.97 338.90 333.82 200.47 128.99 133.94 Short Term Loans & Adv. 28.40 56.48 60.27 1,468.58 1,513.25 232.20 310.58 112.04 71.19 58.18 Net Current Assets 2,009.60 848.06 752.93 555.14 586.54 954.01 1,594.52 1,480.43 1,735.03 1,810.27 Total Assets 4,520.13 3,011.52 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56 3,037.24 3,001.68

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Cash From Operating Activity 819.79 594.87 490.97 411.18 474.77 232.28 138.27 340.88 267.42 293.63 PBT 2,470.04 722.33 646.99 658.82 523.78 465.35 573.63 800.50 703.17 994.78 Adjustment -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 -180.38 -178.80 Changes in Working Capital 134.89 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 1.66 38.79 Cash after chg. in Working capital 968.00 760.11 704.78 620.71 676.33 390.46 353.51 597.94 524.44 854.76 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 -242.05 -313.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -36.06 -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 -14.97 -247.33 Cash From Investing Activity -419.66 407.57 -63.10 -154.44 -107.01 303.08 499.09 177.62 197.98 -92.58 Net Fixed Assets -23.04 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 Net Investments -365.45 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 Others -31.17 -551.19 -52.52 55.20 313.67 710.96 566.67 241.09 198.17 -121.81 Cash from Financing Activity -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -490.08 -437.07 Net Cash Inflow / Outflow -124.11 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 -24.68 -236.01 Opening Cash & Equivalents 404.90 98.03 97.78 199.40 138.27 113.68 114.66 93.50 137.07 373.08 Closing Cash & Equivalent 280.79 404.90 98.03 97.78 199.40 138.27 113.68 115.01 112.39 137.07

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Cash From Operating Activity 810.75 577.91 490.50 409.49 472.80 234.37 138.90 337.64 281.31 313.59 PBT 2,475.65 723.10 647.25 653.97 522.17 465.46 576.08 807.56 685.30 982.58 Adjustment -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 -156.37 -159.63 Changes in Working Capital 119.87 45.75 44.07 -4.19 164.56 -26.69 -124.41 -36.90 11.45 56.35 Cash after chg. in Working capital 959.04 743.20 704.49 618.41 674.55 392.29 355.67 597.00 540.37 879.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 -244.09 -318.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -36.06 -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 0.00 0.00 Cash From Investing Activity -405.51 418.03 -56.84 -153.45 -104.19 300.64 499.02 180.01 188.98 -109.65 Net Fixed Assets -23.04 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 Net Investments -365.45 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 Others -17.02 -540.73 -46.26 56.19 316.49 708.52 566.60 243.48 189.17 -138.88 Cash from Financing Activity -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -494.14 -440.63 Net Cash Inflow / Outflow -119.00 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 -23.85 -236.69 Opening Cash & Equivalents 405.19 104.81 98.78 201.10 139.13 114.89 115.30 94.93 137.67 374.36 Closing Cash & Equivalent 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.59 113.82 137.67

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Book Value (Rs.) 158.06 88.37 108.62 126.47 122.78 119.72 130.14 109.30 119.07 118.65 ROA 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% 16.56% 19.39% ROE 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% 24.92% 29.38% ROCE 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% 36.16% 43.00% Fixed Asset Turnover 5.86 3.04 3.21 6.48 8.22 11.35 10.32 11.16 9.33 10.09 Receivable days 21.71 18.45 12.47 15.60 20.03 18.12 14.65 10.40 14.54 13.39 Inventory Days 53.45 58.87 54.87 57.56 58.34 57.72 57.50 37.61 42.77 40.75 Payable days 140.09 117.18 57.46 72.90 65.55 50.91 53.40 43.13 48.42 47.09 Cash Conversion Cycle -64.93 -39.85 9.88 0.26 12.81 24.94 18.76 4.88 8.89 7.05 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 389.70 129.34 51.90 1198.38 2865.01 2045.32 1368.05 1597.21 2205.05 2534.09

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12
Book Value (Rs.) 157.19 87.26 107.47 126.31 121.44 118.46 128.88 107.96 117.45 118.46 ROA 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% 15.95% 18.82% ROE 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% 24.10% 28.50% ROCE 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% 35.54% 42.24% Fixed Asset Turnover 5.96 3.04 3.21 6.48 8.21 11.38 9.59 9.82 8.13 8.74 Receivable days 21.34 18.42 12.47 15.60 20.03 18.09 14.59 10.35 14.45 13.29 Inventory Days 54.85 60.14 54.88 57.56 58.36 57.89 57.97 38.01 43.02 40.86 Payable days 139.50 119.53 57.89 73.24 66.07 51.56 53.81 43.72 49.18 47.40 Cash Conversion Cycle -63.31 -40.97 9.45 -0.07 12.32 24.42 18.75 4.64 8.28 6.75 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 391.29 129.56 49.26 1232.59 2856.45 2045.74 1373.88 1612.26 2146.51 2497.59

Top Investors:

lici health protection plus fund

general insurance corporation of india

Annual Reports:

News Update:

LIC sells 2.04% stake in Glaxosmithkline Pharma
15th Sep 2022, 10:07 AM

With this, LIC's shareholding in the company reduced to 4.35 percent
Read More
Glaxosmithkline Pharmaceuticals reports marginal fall Q1 consolidated net profit
26th Jul 2022, 15:25 PM

Total consolidated income of the company increased by 3.01% at Rs 772.71 crore for Q1FY23
Read More
Glaxosmithkline Phar - Quarterly Results
25th Jul 2022, 17:40 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback